Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil + tamsulosin versus tamsulosin alone for benign prostatic hyperplasia
PACTR202311592558473Phase 3Not yet recruiting
- Sponsor
- Atobatele Kazeem
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tadalafil and tamsulosin in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Atobatele Kazeem. Primary endpoint: International Prostatic Symptoms Score. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
tadalafiltamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on PACTR202311592558473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202311592558473.